OBJECTIVE: The purpose of this study is to analyze clinical aspects and disease-free survival (DFS) in children less than 3 years of age diagnosed with low-grade astrocytoma. METHODS: In a period of 24 years (1980-2004), a total of 43 (5.4%) children were registered with these characteristics. Twenty-three patients had pilocytic astrocytoma, 18 diffused, and 2 mixed. Thirty-one (72.1%) children had incomplete surgical tumor resection and 12 (27.9%) had a complete tumor resection. Twelve (27.9%) patients had cranial radiotherapy and 17 (39.5%) received chemotherapy. Overall survival was recorded in 23 (53%). DFS was 50% at 250 months of follow-up for the whole group. DFS for the supratentorial group was 60% at 250 months, whereas, for the infratentorial, it was 22% at 120 months (p = 0.008). CONCLUSION: The only favorable prognostic pattern was the supratentorial presentation. Radiotherapy and chemotherapy did not alter the outcome.
OBJECTIVE: The purpose of this study is to analyze clinical aspects and disease-free survival (DFS) in children less than 3 years of age diagnosed with low-grade astrocytoma. METHODS: In a period of 24 years (1980-2004), a total of 43 (5.4%) children were registered with these characteristics. Twenty-three patients had pilocytic astrocytoma, 18 diffused, and 2 mixed. Thirty-one (72.1%) children had incomplete surgical tumor resection and 12 (27.9%) had a complete tumor resection. Twelve (27.9%) patients had cranial radiotherapy and 17 (39.5%) received chemotherapy. Overall survival was recorded in 23 (53%). DFS was 50% at 250 months of follow-up for the whole group. DFS for the supratentorial group was 60% at 250 months, whereas, for the infratentorial, it was 22% at 120 months (p = 0.008). CONCLUSION: The only favorable prognostic pattern was the supratentorial presentation. Radiotherapy and chemotherapy did not alter the outcome.
Authors: Maryam Fouladi; Daniel L Hunt; Ian F Pollack; Gregor Dueckers; Peter C Burger; Laurence E Becker; Allen J Yates; Floyd H Gilles; Richard L Davis; James M Boyett; Jonathan L Finlay Journal: Cancer Date: 2003-09-15 Impact factor: 6.860
Authors: Dennis J Kuo; Howard L Weiner; Jeffrey Wisoff; Douglas C Miller; Edmond A Knopp; Jonathan L Finlay Journal: J Pediatr Hematol Oncol Date: 2003-05 Impact factor: 1.289
Authors: Shih-Shan Lang; Lauren A Beslow; Brandon Gabel; Alex R Judkins; Michael J Fisher; Leslie N Sutton; Phillip B Storm; Gregory G Heuer Journal: World Neurosurg Date: 2011-11-07 Impact factor: 2.104
Authors: Donna L Johnston; Daniel Keene; Ute Bartels; Anne-Sophie Carret; Bruce Crooks; David D Eisenstat; Chris Fryer; Lucie Lafay-Cousin; Valerie Larouche; Albert Moghrabi; Beverly Wilson; Shayna Zelcer; Mariana Silva; Eric Bouffet Journal: J Neurooncol Date: 2015-05-13 Impact factor: 4.130